Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies

References

• Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–558.
   PubMed Web of Science ®Google Scholar
• Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816–1821.
   PubMed Web of Science ®Google Scholar
• Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92:e1029–e40.
   PubMed Web of Science ®Google Scholar
• Leray E, Moreau T, Fromont A, et al. Epidemiology of multiple sclerosis. Rev Neurol (Paris). 2016;172:3–13.
   PubMed Web of Science ®Google Scholar
• Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010;9:A387–94.
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–1517.
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–1231.
   PubMed Web of Science ®Google Scholar
• Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther. 2005;106:163–177.
   PubMed Web of Science ®Google Scholar
• Gobel K, Ruck T, Meuth SG. Cytokine signaling in multiple sclerosis: lost in translation. Mult Scler. 2018;24:432–439.
   PubMed Web of Science ®Google Scholar
• Ramaglia V, Rojas O, Naouar I, et al. The ins and outs of central nervous system inflammation-lessons learned from multiple sclerosis. Annu Rev Immunol. 2021;39:199–226.
   PubMed Web of Science ®Google Scholar
• Wood H. Microglial changes associated with meningeal inflammation in multiple sclerosis. Nat Rev Neurol. 2021;17:262.
   Google Scholar
• Haase S, Linker RA. Inflammation in multiple sclerosis. Ther Adv Neurol Disord. 2021;14:17562864211007687.
   Web of Science ®Google Scholar
• Pickering M, Cumiskey D, O’Connor JJ. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol. 2005;90:663–670.
   PubMed Web of Science ®Google Scholar
• Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNFalpha. Science. 2002;295:2282–2285.
   PubMed Web of Science ®Google Scholar
• Canedo T, Portugal CC, Socodato R, et al. Astrocyte-derived TNF and glutamate critically modulate microglia activation by methamphetamine. Neuropsychopharmacol. 2021;46:2358–2370.
   PubMed Web of Science ®Google Scholar
• Pan W, Kastin AJ. Upregulation of the transport system for TNFalpha at the blood-brain barrier. Arch Physiol Biochem. 2001;109:350–353.
   PubMedGoogle Scholar
• Kristensen LB, Lambertsen KL, Nguyen N, et al. The role of non-selective TNF inhibitors in demyelinating events. Brain Sci. 2021;11:38.
   PubMed Web of Science ®Google Scholar
• Huang Y, Erdmann N, Peng H, et al. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol. 2005;2:113–122.
   PubMed Web of Science ®Google Scholar
• Butovsky O, Landa G, Kunis G, et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest. 2006;116:905–915.
   PubMed Web of Science ®Google Scholar
• Simpson SsJr., Stewart N, van der Mei I, et al. Stimulated PBMC-produced IFN-gamma and TNF-alpha are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study. J Neurol Neurosurg Psychiatry. 2015;86:200–207.
   PubMed Web of Science ®Google Scholar
• Kallaur AP, Oliveira SR, Simao ANC, et al. Cytokine profile in patients with progressive multiple sclerosis and its association with disease progression and disability. Mol Neurobiol. 2017;54:2950–2960.
   PubMed Web of Science ®Google Scholar
• Skurkovich S, Boiko A, Beliaeva I, et al. Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosis. Mult Scler. 2001;7:277–284.
   PubMedGoogle Scholar
• Panitch HS, Hirsch RL, Haley AS, et al. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1987;1:893–895.
   PubMed Web of Science ®Google Scholar
• Panitch HS, Hirsch RL, Schindler J, et al. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 1987;37:1097–1102.
   PubMed Web of Science ®Google Scholar
• Hutto SK, Rice DR, Mateen FJ. CNS demyelination with TNFalpha inhibitor exposure: a retrospective cohort study. J Neuroimmunol. 2021;356:577587.
   PubMed Web of Science ®Google Scholar
• Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195–3199.
   PubMed Web of Science ®Google Scholar
• Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997;72:149–153.
   PubMed Web of Science ®Google Scholar
• Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991;173:209–219.
   PubMed Web of Science ®Google Scholar
• Fernandes Filho JA, Vedeler CA, Myhr KM, et al. TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity. 2002;35:377–380.
   PubMed Web of Science ®Google Scholar
• Rossouw M, Nel HJ, Cooke GS, et al. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet. 2003;361:1871–1872.
   PubMed Web of Science ®Google Scholar
• Nikolopoulos GK, Masgala A, Tsiara C, et al. Cytokine gene polymorphisms in multiple sclerosis: a meta-analysis of 45 studies including 7379 cases and 8131 controls [Review]. Eur J Neurol. 2011;18:944–E75.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun R, Yang H, et al. -308 G > A of TNF-α gene promoter decreases the risk of multiple sclerosis: a meta-analysis. Mult Scler. 2011;17:658–665.
   PubMed Web of Science ®Google Scholar
• Xu L, Yuan W, Sun H, et al. The polymorphisms of the TNF-α gene in multiple sclerosis?–a meta-analysis. Mol Biol Rep. 2011;38:4137–4144.
   PubMed Web of Science ®Google Scholar
• Tolide-Ie H, Tabatabaee HR, Kamali-Sarvestani E. Association between tumor necrosis factor- α-308 G/A polymorphism and multiple sclerosis: a systematic review and meta-analysis. Iran J Med Sci. 2014;39:2–10.
   PubMedGoogle Scholar
• Gao LB, Pan XM, Li LJ, et al. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2011;125:827–835.
   PubMed Web of Science ®Google Scholar
• Yang P, Wang L, Tang X, et al. The methylenetetrahydrofolate reductase 1298 A>C polymorphism is associated with an increased risk of inflammatory bowel disease: evidence from a meta-analysis. Expert Rev Clin Immunol. 2021;17:1221–1229.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Kamali-Sarvestani E, Nikseresht A, Aflaki E, et al. TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol Scand. 2007;115:161–166.
   PubMed Web of Science ®Google Scholar
• Shokrgozar MA, Sarial S, Amirzargar A, et al. IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. J Clin Immunol. 2009;29:747–751.
   PubMed Web of Science ®Google Scholar
• Asgharzadeh M, Najafi-Ghalehlou N, Poor BM, et al. IFN-γ and TNF-α gene polymorphisms in multiple sclerosis patients in Northwest Iran. Endocr Metab Immune Disord Drug Targets. 2021;21:520–525.
   PubMed Web of Science ®Google Scholar
• Ristić S, Lovrecić L, Starcević-Cizmarević N, et al. Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur Neurol. 2007;57:203–207.
   PubMed Web of Science ®Google Scholar
• Drulović J, Popadić D, Mesaros S, et al. Decreased frequency of the tumor necrosis factor alpha −308 allele in Serbian patients with multiple sclerosis. Eur Neurol. 2003;50:25–29.
   PubMed Web of Science ®Google Scholar
• Shahbazi M, Roshandel D, Omidnyia E, et al. Interaction of HLA-DRB1*1501 allele and TNF-alpha −308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Clin Immunol. 2011;139:277–281.
   PubMed Web of Science ®Google Scholar
• Izad M, Vodjgani M, Niknam MH, et al. Cytokines genes polymorphisms and risk of multiple sclerosis. Am J Med Sci. 2010;339:327–331.
   PubMed Web of Science ®Google Scholar
• Fernandez-Arquero M, Arroyo R, Rubio A, et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology. 1999;53:1361–1363.
   PubMed Web of Science ®Google Scholar
• He B, Navikas V, Lundahl J, et al. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol. 1995;63:143–147.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Ji H, Ye Z, et al. Correlation between tumor necrosis factor α and β gene polymorphisms and multiple sclerosis. Chin J Neuromed. 2006;5:572–575.
   Google Scholar
• Dong Y, Lin P, Liang Y, et al. Association between polymorphisms of TNF genes and Multiple Sclerosis (MS) in Han nationality of Guangdong. J Trop Med. 2006;6:1088–1091.
   Google Scholar
• Kallaur AP, Oliveira SR, Simão AN, et al. Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1. J Mol Neurosci. 2014;53:211–221.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun W, Zhu G, et al. Relationship between gene polymorphism of TNF-α, β and multiple sclerosis. J Fourth Mil Med Univ. 2009;30:1953–1955.
   Google Scholar
• Shen Y, Gao C, Yang N, et al. Association between tumor necrosis factor-β gene polymorphisms and multiple sclerosis (MS) in Han nationality of Guangdong. Guangdong Med J. 2005;36:10–12.
   Google Scholar
• Song X, Guo L, Li B, et al. Association between tumor necrosis factor beta gene polymorphisms and multiple sclerosis. Chin J Nerv Ment Dis. 2008;34:76–78.
   Google Scholar
• Vandevyver C, Raus P, Stinissen P, et al. Polymorphism of the tumour necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur J Immunogenet. 1994;21:377–382.
   PubMedGoogle Scholar
• Makarycheva OY, Tsareva EY, Sudomoina MA, et al. Linkage and association of proinflammatory cytokines genes IL-6, IFNG and TNF with multiple sclerosis [Article]. Mol Biol. 2010;44:728–733.
   Web of Science ®Google Scholar
• Mihailova S, Ivanova M, Mihaylova A, et al. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J Neuroimmunol. 2005;168:138–143.
   PubMed Web of Science ®Google Scholar
• Sarial S, Shokrgozar MA, Amirzargar A, et al. IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol. 2008;7:37–40.
   PubMed Web of Science ®Google Scholar
• Bakr NM, Hashim NA, El-Baz HAE, et al. Polymorphisms in proinflammatory cytokines genes and susceptibility to multiple sclerosis. Mult Scler Relat Disord. 2021;47:102654.
   PubMed Web of Science ®Google Scholar
• Trenova AG, Miteva LD, Stanilova SA. Association between TNFA, IL10 and IL18 promoter gene variants and cognitive functions in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol. 2020;347:577357.
   PubMed Web of Science ®Google Scholar
• Grigorova AA, Trenova AG, Stanilova SA. Association of polymorphism −308G/A in tumor necrosis factor-alpha gene (TNF-α) and TNF-α serum levels in patients with relapsing-remitting multiple sclerosis. Neurol Res. 2021;43:291–298.
   PubMed Web of Science ®Google Scholar
• Losonczi E, Bencsik K, Nagy ZF, et al. Tumour necrosis factor alpha gene (TNF-alpha) −376 polymorphism in Hungarian patients with primary progressive multiple sclerosis. J Neuroimmunol. 2009;208:115–118.
   PubMed Web of Science ®Google Scholar
• Weinshenker BG, Hebrink DD, Atkinson E, et al. Association of a tumor necrosis factor alpha polymorphism with MS susceptibility. Neurology. 2001;57:1341–1342.
   PubMed Web of Science ®Google Scholar
• Schwartzentruber J, Cooper S, Liu JZ, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat Genet. 2021;53:392–402.
   PubMed Web of Science ®Google Scholar
• Abell NS, DeGorter MK, Gloudemans MJ, et al. Multiple causal variants underlie genetic associations in humans. Science. 2022;375:1247–1254.
   PubMed Web of Science ®Google Scholar